Stelac Advisory Services’s Pfizer PFE Stock Holding History

Stelac Advisory Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-126,698	Closed	-$3.52M	–	177
2026 Q1	$3.52M	Buy	+126,698	New	+$3.37M	0.71%	42
2022 Q4	–	Sell	-2,787	Closed	-$122K	–	166
2022 Q3	$122K	Buy	2,787 +20	+0.7%	+$972	0.06%	145
2022 Q2	$145K	Buy	2,767 +732	+36%	+$37.3K	0.06%	146
2022 Q1	$105K	Sell	2,035 -732	-26%	-$38K	0.04%	169
2021 Q4	$163K	Buy	+2,767	New	+$137K	0.04%	150
2021 Q3	–	Sell	-3,458	Closed	-$135K	–	260
2021 Q2	$135K	Sell	3,458 -664	-16%	-$25.8K	0.03%	245
2021 Q1	$149K	Sell	4,122 -6,050	-59%	-$215K	0.06%	175
2020 Q4	$374K	Buy	10,172 +4,154	+69%	+$152K	0.1%	127
2020 Q3	$210K	Buy	+6,018	New	+$211K	0.07%	130
2019 Q4	–	Sell	-3,977	Closed	-$136K	–	105
2019 Q3	$136K	Buy	+3,977	New	+$145K	0.1%	92
2019 Q2	–	Sell	-4,752	Closed	-$197K	–	116
2019 Q1	$197K	Hold	4,752	–	–	0.09%	57
2018 Q4	$197K	Sell	4,752 -2,529	-35%	-$105K	0.1%	53
2018 Q3	$304K	Buy	7,281 +157	+2%	+$6.04K	0.09%	56
2018 Q2	$245K	Hold	7,124	–	–	0.07%	71
2018 Q1	$240K	Buy	7,124 +4,095	+135%	+$141K	0.07%	62
2017 Q4	$104K	Sell	3,029 -28,023	-90%	-$956K	0.04%	65
2017 Q3	$1.05M	Buy	31,052 +8,538	+38%	+$274K	0.32%	26
2017 Q2	$718K	Hold	22,514	–	–	0.24%	28
2017 Q1	$731K	Sell	22,514 -832	-4%	-$26.2K	0.23%	28
2016 Q4	$719K	Buy	+23,346	New	+$713K	0.24%	27
2016 Q3	–	Sell	-3,287	Closed	-$110K	–	64
2016 Q2	$110K	Buy	+3,287	New	+$105K	0.03%	67

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stelac Advisory Services's PFE Position: Q2 2026 in Review

Stelac Advisory Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 126,698 shares — an estimated $3.52M sold.

Stelac Advisory Services first reported a position in PFE in Q2 2016 and held it in 21 quarters. The position peaked at $3.52M in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Stelac Advisory Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Stelac Advisory Services sold 126,698 Pfizer shares in Q2 2026, an estimated $3.52M.
Stelac Advisory Services first reported a position in Pfizer in Q2 2016 and held it in 21 quarters.
Stelac Advisory Services's Pfizer position peaked at $3.52M in Q1 2026.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Stelac Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.